What Does it Cost? An economic analysis of a harm reduction intervention in Svetlogorsk, Belarus

Drugs: Education, Prevention and Policy

Volumn 8, Issue 4, 2001, Pages 384-395

  Walker, Damian ^a   Kumaranayake, Lilani ^a   Romantsov, Vladimir ^b   Samoshkin, Svyatoslav ^b   Zviagin, Victor ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NGO Parents Fut of Their Children ^*  (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0348238300     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BALL, A.L., RANA, S. & DEHNE, K.L. (1998). HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Reports, 13(Suppl 1), pp. S170-81.
2. DEHNE, K.L., KHODAKEVICH L., HAMERS, F.F. & SCHWARTLANDER, B. (1999). The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making. AIDS, 13, pp. 741-9.
3. HOLTGRAVE, D.R., PINKERTON, D.S., JONES, T.S., LURIE, P. & VLAHOV, D. (1998). Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), pp. S133-8.
4. KOESTER, S. (1998). Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), pp. S139-40.
5. KUMARANAYAKE, L. & WALKER, D. (2000). Costing Guidelines for HIV/AIDS Prevention Strategies Among Injecting Drug User Populations. London: Health Economics and Financing Programme, London School of Hygiene & Tropical Medicine.
6. LURIE, P., GORSKY, R., JONES, S. & SHOMPHE, L. (1998). An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), pp. S126-32.
7. MCCOY, C.B., METSCH, L.R., CHITWOOD, D.D., SHAPSHAK, P. & COMERFORD, S.T. (1998). Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needle, syringes, cookers, cotton and water. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), pp. S25-9.
8. NEEDLE, R.H., COYLE, S.L., NORMAN, J., LAMBERT, E. & CESARI, H. (1998). HIV prevention with drug-using populations - current status and future prospects: introduction and overview. Public Health Reports, 13 (Suppl 1), pp. 4-30.
9. STRATHDEE, S.A., VAN AMEIJIDEN, E.J.C., MESQUITA, F., WODAK, A., RANA, S. & VLAHOV, D. (1998). Can HIV epidemics among injecting drug users be prevented? AIDS, 12(Suppl A), pp. S71-9.
10. UNAIDS (1999). AIDS Epidemic Update: December 1999. Geneva: UNAIDS.
11. WALKER, D., VICKERMAN, P., KUMARANAYAKE, L., ZVIAGIN, V., SAMOSHKIN, S., ROMANTSOV, V. & WATTS, C. (2000). Responding to HIV/AIDS in Belarus: the importance of early intervention. eurohealth, 6(1), pp. 53-5.
12. WATTS, C., KUMARANAYAKE, L. & VICKERMAN, P. (1999). HIVTools: a toolkit to estimate the impact and cost-effectiveness of HIV prevention strategies. XI International Conference on AIDs and STDs in Africa, Lusaka (Abstract 13PT21-8).
13. WORLD BANK (1993). World Development Report: investing in health. New York: Oxford University Press.